for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Jiangsu Kanion Pharmaceutical Co., Ltd.

600557.SS

Latest Trade

17.22CNY

Change

-0.04(-0.23%)

Volume

3,226,583

Today's Range

17.12

 - 

17.42

52 Week Range

8.24

 - 

17.55

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
17.26
Open
17.26
Volume
3,226,583
3M AVG Volume
101.78
Today's High
17.42
Today's Low
17.12
52 Week High
17.55
52 Week Low
8.24
Shares Out (MIL)
592.88
Market Cap (MIL)
10,209.41
Forward P/E
19.51
Dividend (Yield %)
0.46

Latest Developments

More

Jiangsu Kanion Pharmaceutical Agrees To Buy Technology Firm For 269.4 Million Yuan

Jiangsu Kanion Pharmaceutical Plans Share Buyback Worth Up To 250 Mln Yuan Within Three Months

Jiangsu Kanion Pharmaceutical to pay cash dividend of 0.6 yuan (pre-tax) for every 10 shares

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Jiangsu Kanion Pharmaceutical Co., Ltd.

Jiangsu Kanion Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company provides capsules, oral liquid, granules, electuary, tablets, pills, patch and injections. The Company's products are applied in gynecology, orthopedics, cardiovascular and cerebrovascular, anti-infective, anti-tumor and others. The Company distributes its products mainly within domestic markets.

Industry

Biotechnology & Drugs

Contact Info

Jiangning Industrial Park

Economic & Technological Development Zne

+86.518.85521990

http://www.kanion.com

Executive Leadership

Wei Xiao

Chairman of the Board, General Manager, Chief Engineer

Yin Yang

Vice Chairman of the Board

Youlong Chen

Chief Financial Officer

Yongchun Yang

Chief Marketing Officer, Deputy General Manager

Ya Ling

Executive Deputy General Manager, Director

Key Stats

1.80 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2016

3.0K

2017

3.3K

2018

3.8K

2019(E)

4.7K
EPS (CNY)

2016

0.610

2017

0.606

2018

0.730

2019(E)

0.883
Price To Earnings (TTM)
21.00
Price To Sales (TTM)
2.41
Price To Book (MRQ)
2.77
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
19.43
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
12.73
Return on Equity (TTM)
8.40

Latest News

BRIEF-Lock-up period for Jiangsu Kanion Pharmaceutical's 153.2 mln shares to end

* Says lock-up period for 153.2 million shares to end, trading to start on Sept 8

BRIEF-Jiangsu Kanion Pharmaceutical to pay A shares annual div for FY 2016 on June 15

* Says it will pay cash dividend of 0.06 yuan(before tax)/share for 2016 to shareholders of record on June 14

BRIEF-Jiangsu Kanion Pharmaceutical to pay cash 0.6 yuan per 10 shares as FY 2016 div payment

* Says it plans to pay cash 0.6 yuan per 10 shares as FY 2016 div payment

BRIEF-Jiangsu Kanion Pharmaceutical to set up pharma JV

* Says it plans to set up pharma JV with registered capital at 200 million yuan ($29.94 million)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up